MRVI Stock Price, Chart, Stats & News
Maravai LifeSciences Holdings, Inc. (MRVI) does not currently pay a dividend.
MRVI chart
Fundamentals
Gross margin | 17.98% |
Operating margin | -3.63% |
Pretax margin | -126.50% |
Net margin | -70.41% |
Effective tax rate | 1.79% |
ROA | -16.97% |
ROE | -51.07% |
D/E | 0.17x |
Interest coverage ratio | -0.25x |
MRVI valuation
P/E | – |
P/S | 4.23x |
P/B | 1.95x |
P/CF | -7.21x |
P/FCF | -11.11x |
P/OCF | -7.21x |
PEG | 0.38x |
EV multiple | -6.57x |
About
Maravai LifeSciences Holdings, Inc. is a life sciences company operating globally, supplying essential products that facilitate the advancement of drug therapies, diagnostics, innovative vaccines, and research into human diseases. Its diverse product line supports critical stages of biopharmaceutical development, featuring nucleic acids for both diagnostic and therapeutic applications, antibody-based solutions for detecting impurities in biopharmaceutical manufacturing, and tools for monitoring protein expression across different tissue types. The company conducts its operations through two distinct segments: Nucleic Acid Production and Biologics Safety Testing.
Similar securities
Based on sector and market capitalization
